Diabetes Clinical Trials in Baltimore

Showing 21-40 of 651 trials

Study of a Primary Care Hypoglycemia Prevention Program

NCT06353217

This is a single site, pre-post pilot study. The objective is to evaluate the acceptability and feasibility of a primary care hypoglycemia prevention program for patients taking hypoglycemia-causing medications. The study will also evaluate relevant process outcomes and clinical outcomes for refining the intervention and planning for a larger efficacy trial.

Diabetes MellitusHypoglycemia

Johns Hopkins University35 participantsStarted May 2024

Baltimore, Maryland, United States

COMPLETEDPhase 1< 1 mile

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

NCT06362265

The main purpose of this study is to evaluate how much of LY3209590 gets into the blood stream after a single dose and how long it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 days.

Type 2 Diabetes Mellitus

Eli Lilly and Company15 participantsStarted Oct 2024

Los Angeles, California, United States • Atlanta, Georgia, United States • Columbus, Georgia, United States +7 more locations

Study of a Primary Care Hypoglycemia Prevention Program

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

Diabetes Trials in Other Cities

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Genetic Studies of Insulin and Diabetes

Developing the Family Map: Looking at Communal Coping

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Closed Loop and Education for Hypoglycemia Awareness Restoration

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Type 1 Diabetes Extension Study

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)

Other Conditions in Baltimore